Rapid treatment of "wearing off" in Parkinson's disease
- PMID: 15037669
- DOI: 10.1212/wnl.62.6_suppl_4.s27
Rapid treatment of "wearing off" in Parkinson's disease
Abstract
Patients with advanced Parkinson's disease (PD) may develop a variety of motor complications associated with levodopa therapy. Motor fluctuations, such as early morning akinesia and "wearing-off," may respond to individualized medical management with titrated combinations of levodopa, dopamine agonists, COMT inhibitors and amantadine. Often with disease progression, dyskinesias and unpredictable, rapid "off" periods will also emerge. These motor complications are less amenable to traditional anti-parkinson therapy manipulation. This manuscript reviews approaches for "rescue" therapy in PD patients with "wearing off," sudden "offs," early morning akinesia, and variable response to individual doses of oral medications. Strategies for preparing and administering liquid levodopa are discussed within the context of gastric emptying, intestinal absorption, and active transport across the blood brain barrier. In addition other levodopa preparations in early development, including the orally administered levodopa methyl ester and the potential for a subcutaneously administered levodopa ethyl ester are reviewed. Furthermore, practical guidelines regarding the dosing, administration, use of the antiemetic trimethobenzamide (Tigan), time to "on," duration of benefit, and potential side effects associated with subcutaneously injected apomorphine are provided.
Similar articles
-
A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.Clin Ther. 2005 Nov;27(11):1710-24. doi: 10.1016/j.clinthera.2005.11.016. Clin Ther. 2005. PMID: 16368444 Review.
-
Medical management of levodopa-associated motor complications in patients with Parkinson's disease.CNS Drugs. 2007;21(8):677-92. doi: 10.2165/00023210-200721080-00005. CNS Drugs. 2007. PMID: 17630819 Review.
-
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.Clin Neuropharmacol. 1996 Jun;19(3):193-201. doi: 10.1097/00002826-199619030-00001. Clin Neuropharmacol. 1996. PMID: 8726538 Clinical Trial.
-
Other pharmacological treatments for motor complications and dyskinesias.Mov Disord. 2005;20 Suppl 11:S38-44. doi: 10.1002/mds.20462. Mov Disord. 2005. PMID: 15822104 Review.
-
Practical considerations in the use of apomorphine injectable.Neurology. 2004 Mar 23;62(6 Suppl 4):S32-6. doi: 10.1212/wnl.62.6_suppl_4.s32. Neurology. 2004. PMID: 15037670 Review.
Cited by
-
Optimising levodopa therapy for the management of Parkinson's disease.J Neurol. 2005 Oct;252 Suppl 4:IV43-IV48. doi: 10.1007/s00415-005-4009-4. J Neurol. 2005. PMID: 16222437 Review.
-
Chronobiology of Parkinson's disease: Past, present and future.Eur J Neurosci. 2023 Jan;57(1):178-200. doi: 10.1111/ejn.15859. Epub 2022 Nov 23. Eur J Neurosci. 2023. PMID: 36342744 Free PMC article. Review.
-
Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.Drugs Aging. 2007;24(8):663-80. doi: 10.2165/00002512-200724080-00004. Drugs Aging. 2007. PMID: 17702535 Review.
-
Too little or too much nocturnal movements in Parkinson's disease: A practical guide to managing the unseen.Clin Park Relat Disord. 2024 May 25;10:100258. doi: 10.1016/j.prdoa.2024.100258. eCollection 2024. Clin Park Relat Disord. 2024. PMID: 38845753 Free PMC article.
-
Patients' Preferences for Adjunctive Parkinson's Disease Treatments: A Discrete-Choice Experiment.Patient Prefer Adherence. 2023 Sep 13;17:2263-2277. doi: 10.2147/PPA.S420051. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37724313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous